Baby Safety / Compounds / Brahmanol

Is Brahmanol safe for babies and kids?

Low risk for kids

(Babies-specific data is limited; this page draws from human adult context.) Brahmanol poses low risk to adults under normal use conditions.

What is brahmanol?

The IUPAC name is cyclobutyl-1,2-benzisothiazole derivative.

Also known as: cyclobutyl-1,2-benzisothiazole derivative, woody, 1,2,3,4,4a,5,6,7-Octahydro-2,5,5-trimethyl-2-naphthol, 1,2,3,4,4a,5,6,7-Octahydro-2,5,5-trimethyl-2-naphthalenol.

IUPAC name
cyclobutyl-1,2-benzisothiazole derivative
CAS number
41199-19-3
Molecular formula
C13H22O
Molecular weight
194.31 g/mol
SMILES
CC1(CCC=C2C1CCC(C2)(C)O)C
PubChem CID
162452

Risk for babies

Low risk

Brahmanol poses low risk to adults under normal use conditions.

Regulatory consensus

2 regulatory and scientific bodies have classified Brahmanol. The classifications differ — that's the data.

AgencyYearClassificationNotes
IFRA——IFRA standard
EU——EU approved

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter brahmanol

  • Perfume
  • Personal Care

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Brahmanol:

  • Fragrance-free product formulations
    Trade-offs: Eliminates allergen risk entirely; consumer acceptance varies (some associate scent with cleanliness/efficacy); growing market segment; regulatory advantage in EU (no IFRA compliance needed).
    Relative cost: Lower (ingredient elimination)
  • Essential oil-free synthetic fragrance blends with established safety profiles
    Trade-offs: Allows scent without specific natural allergens; synthetic molecules can be individually safety-tested; some synthetics have their own sensitization profiles; cost comparable to natural blends.
    Relative cost: Lower (ingredient elimination)
  • Encapsulated fragrance technologies (reduced dermal contact)
    Trade-offs: Reduces dermal contact by 60-90% via polymer shell release mechanism; higher formulation cost; may alter scent perception (delayed release); shell material itself requires safety assessment.
    Relative cost: 1.2-2×
  • Naturally-derived isolates at IFRA-compliant concentrations
    Trade-offs: Alternative fragrance ingredient; individual safety profile should be assessed per IFRA standards; sensitization potential varies by compound; patch testing recommended for sensitive individuals.
    Relative cost: 2-5× conventional

Frequently asked questions

No FAQ entries generated.

See Brahmanol in the baby app

Look up products containing brahmanol, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. ATSDR Toxicological Profile — CAS 41199-19-3 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →